Viridian Therapeutics, Inc.\DE (VRDN) EBITDA Margin Growth (1y) (2014 - 2026)
Viridian Therapeutics, Inc.\DE (VRDN) EBITDA Margin Growth (1y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 1,552.00 |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 1,536.00 |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | -170.00 |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 1,276.00 |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Viridian Therapeutics, Inc.\DE | 631.55 Mn | 631.55 Mn | - | 4.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.80 Mn |
| Dec 31, 2025 | 2.85 Mn |
| Sep 30, 2025 | 9.70 Mn |
| Jun 30, 2025 | -4.21 Mn |
| Mar 31, 2025 | -5.27 Mn |
| Dec 31, 2024 | -2.22 Mn |
| Sep 30, 2024 | -2.59 Mn |
| Jun 30, 2024 | -1.79 Mn |
| Mar 31, 2024 | -368,268.00 |
| Dec 31, 2023 | -5.25 Mn |
| Sep 30, 2023 | -6.87 Mn |
| Jun 30, 2023 | -7.08 Mn |
| Mar 31, 2023 | -6.20 Mn |
| Dec 31, 2022 | -3.31 Mn |
| Sep 30, 2022 | 430,272.00 |
| Jun 30, 2022 | -989,724.00 |
| Mar 31, 2022 | -1.07 Mn |
| Dec 31, 2021 | 15.42 Mn |
| Jun 30, 2021 | 214,285.00 |
| Mar 31, 2021 | -31,007.00 |